Publicaciones en las que colabora con Antonio Ballesta Garcia (9)

2021

  1. Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking

    Addiction Biology, Vol. 26, Núm. 3

  2. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

2020

  1. Antianhedonic and antidepressant effects of Affron® a standardized saffron (Crocus Sativus L.) extract

    Molecules, Vol. 25, Núm. 14

  2. Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala

    Addiction Biology, Vol. 25, Núm. 5

2019

  1. Bupropion, a possible antidepressant without negative effects on alcohol relapse

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 756-765

  2. Estudio de los efectos del tratamiento con antidepresivos sobre el consumo de alcohol

    Estudio de los efectos del tratamiento con antidepresivos sobre el consumo de alcohol

  3. Rethinking the Use of Antidepressants to Treat Alcohol Use Disorders and Depression Comorbidity: The Role of Neurogenesis

    Antidepressants - Preclinical, Clinical and Translational Aspects

2018

  1. Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide

    British Journal of Pharmacology, Vol. 175, Núm. 24, pp. 4464-4479

  2. Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women

    Addiction Biology, Vol. 23, Núm. 6, pp. 1242-1250